Best Antianxiety Medication
Selective Serotonin Reuptake Inhibitors (SSRIs) are the first-line treatment for anxiety disorders due to their efficacy, favorable side effect profile, and strong evidence base. 1
First-Line Medications
SSRIs
- Sertraline (50-175 mg/day) - FDA approved for social anxiety disorder, panic disorder, and PTSD 2
SNRIs (Alternative First-Line)
- Venlafaxine (37.5-225 mg/day) - Suggested for social anxiety disorder 4, 1
- Duloxetine - Particularly useful when anxiety co-occurs with chronic pain 1
Medication Selection Algorithm
Start with an SSRI (particularly sertraline or escitalopram)
- Initial dosing:
- Sertraline: Start at 25-50mg daily
- Escitalopram: Start at 10mg daily
- Titrate gradually based on response and tolerability
- Initial dosing:
If inadequate response or intolerable side effects with first SSRI:
- Try a different SSRI or switch to an SNRI
- Venlafaxine: Start at 37.5mg daily, maximum 225mg daily 1
For specific populations:
- Older adults: Start with lower doses of SSRIs (sertraline or escitalopram)
- Cardiovascular disease: Start with lower doses of sertraline (25mg daily)
- Chronic pain: Consider duloxetine as first-line 1
Important Considerations
Avoid as First-Line
- Benzodiazepines should be avoided for routine use due to:
- Risk of tolerance development
- Addiction potential
- Cognitive impairment
- Paradoxical agitation (occurs in ~10% of patients) 1
Treatment Duration
- Continue medication for at least 9-12 months after symptom remission 1
- Taper gradually when discontinuing to prevent discontinuation syndrome
Monitoring
- Evaluate for side effects and emergence of suicidal ideation
- Monitor treatment effectiveness every 2-4 weeks during medication changes
- Follow-up within 1-2 weeks of medication changes 1
Non-Pharmacological Options
- Cognitive Behavioral Therapy (CBT) is strongly recommended as an effective treatment for anxiety disorders, with evidence suggesting it's equally effective to medications with fewer adverse effects 4, 1
- For social anxiety disorder specifically, CBT based on the Clark and Wells model or the Heimberg model is suggested 4
- Self-help with support based on CBT is an alternative if face-to-face therapy is not desired 4
Common Pitfalls to Avoid
- Starting with benzodiazepines - Despite quick relief, they should not be first-line due to dependence risk
- Inadequate dosing - Many patients require higher doses than initial starting doses
- Premature discontinuation - Treatment should continue for 9-12 months after remission
- Ignoring comorbidities - Adjust medication choice based on comorbid conditions (e.g., duloxetine for chronic pain)
- Not monitoring for side effects - Regular follow-up is essential, especially during dose adjustments
The Japanese Society of Anxiety and Related Disorders/Japanese Society of Neuropsychopharmacology guidelines (2023) emphasize that while these recommendations are evidence-based, treatment decisions should consider the balance between benefits and harms for each individual 4.